Coya Therapeutics Files Form 4
Ticker: COYA · Form: 4 · Filed: 2026-04-09T18:49:58-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Coya Therapeutics insider trading update filed today.
AI Summary
On April 9, 2026, Coya Therapeutics, Inc. filed a Form 4, indicating changes in beneficial ownership of securities. The filing details transactions related to the company's stock, with specific changes to be detailed within the document.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: medium — Form 4 filings can indicate insider confidence or divestment, which may impact stock price.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Issuer
- 0001835022 (company) — Issuer CIK
- 2026-04-09 (date) — Period of Report
- Pavao Mark H (person) — Reporting Person
- 0001297988 (person) — Reporting Person CIK
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
Who is the issuer?
The issuer is Coya Therapeutics, Inc. (CIK: 0001835022).
When was the period of report for this filing?
The period of report was April 9, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001193125-26-149968.
What is the business address of Coya Therapeutics, Inc.?
The business address is 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024.
From the Filing
EDGAR Filing Documents for 0001193125-26-149968 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001193125-26-149968 Filing Date 2026-04-09 Accepted 2026-04-09 18:49:58 Documents 1 Period of Report 2026-04-09 Document Format Files Seq Description Document Type Size 1 4 ownership.html 4 1 4 ownership.xml 4 3839 Complete submission text file 0001193125-26-149968.txt 5281 Mailing Address C/O NITROMED INC 125 SPRING STREET LEXINGTON MA 02421 Business Address Pavao Mark H ( Reporting ) CIK : 0001297988 (see all company filings) Fiscal Year End: 1231 Type: 4 | Act: 34 | File No.: 001-41583 | Film No.: 26852792 Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939 Coya Therapeutics, Inc. ( Issuer ) CIK : 0001835022 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)